|
1
|
De Kouchkovsky I and Abdul-Hay M: ‘Acute
myeloid leukemia: A comprehensive review and 2016 update’. Blood
Cancer J. 6:e4412016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tenen DG: Disruption of differentiation in
human cancer: AML shows the way. Nat Rev Cancer. 3:89–101. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rouli DD: Chromosome aberrations in
leukemia and lymphoma. Ter Arkh. 55:30–35. 1983.(In Russian).
PubMed/NCBI
|
|
4
|
Palanisamy N: Chromosomal translocations
in AML: Detection and prognostic significance. Cancer Treat Res.
145:41–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Martelli MP, Sportoletti P, Tiacci E,
Martelli MF and Falini B: Mutational landscape of AML with normal
cytogenetics: Biological and clinical implications. Blood Rev.
27:13–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cancer Genome Atlas Research Network, ;
Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A,
Hoadley K, Triche TJ Jr, Laird PW, et al: Genomic and epigenomic
landscapes of adult de novo acute myeloid leukemia. N Engl J Med.
368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ilyas AM, Ahmad S, Faheem M, Naseer MI,
Kumosani TA, Al-Qahtani MH, Gari M and Ahmed F: Next generation
sequencing of acute myeloid leukemia: Influencing prognosis. BMC
Genomics. 16 Suppl 1(Suppl 1):S52015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Donnell MR, Tallman MS, Abboud CN,
Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, et
al: Acute myeloid leukemia, version 2.2013. J Natl Compr Canc Netw.
11:1047–1055. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang K, Li M and Hakonarson H: ANNOVAR:
Functional annotation of genetic variants from high-throughput
sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roberts A, Pimentel H, Trapnell C and
Pachter L: Identification of novel transcripts in annotated genomes
using RNA-Seq. Bioinformatics. 27:2325–2329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Trapnell C, Williams BA, Pertea G,
Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ and Pachter
L: Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trapnell C, Hendrickson DG, Sauvageau M,
Goff L, Rinn JL and Pachter L: Differential analysis of gene
regulation at transcript resolution with RNA-seq. Nat Biotechnol.
31:46–53. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reiner A, Yekutieli D and Benjamini Y:
Identifying differentially expressed genes using false discovery
rate controlling procedures. Bioinformatics. 19:368–375. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang H, Wang X, Bowers JE, Ming R, Alam M
and Paterson AH: Unraveling ancient hexaploidy through
multiply-aligned angiosperm gene maps. Genome Res. 18:1944–1954.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lu J, Peatman E, Tang H, Lewis J and Liu
Z: Profiling of gene duplication patterns of sequenced teleost
genomes: Evidence for rapid lineage-specific genome expansion
mediated by recent tandem duplications. BMC Genomics. 13:2462012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aickin M and Gensler H: Adjusting for
multiple testing when reporting research results: The Bonferroni
vs. Holm methods. Am J Public Health. 86:726–728. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie C, Mao X, Huang J, Ding Y, Wu J, Dong
S, Kong L, Gao G, Li CY and Wei L: KOBAS 2.0: A web server for
annotation and identification of enriched pathways and diseases.
Nucleic Acids Res. 39((Web Server issue)): W316–W322. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ostrovsky O, Korostishevsky M, Levite I,
Leiba M, Galski H, Vlodavsky I and Nagler A: Association of
heparanase gene (HPSE) single nucleotide polymorphisms with
hematological malignancies. Leukemia. 21:2296–2303. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mitra AK, Crews KR, Pounds S, Cao X,
Feldberg T, Ghodke Y, Gandhi V, Plunkett W, Dolan ME, Hartford C,
et al: Genetic variants in cytosolic 5′-nucleotidase II are
associated with its expression and cytarabine sensitivity in HapMap
cell lines and in patients with acute myeloid leukemia. J Pharmacol
Exp Ther. 339:9–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu CY, Hsu YH, Pan PC, Wu MT, Ho CK, Su
L, Xu X, Li Y and Christiani DC; Kaohsiung Leukemia Research Group,
: Maternal and offspring genetic variants of AKR1C3 and the risk of
childhood leukemia. Carcinogenesis. 29:984–990. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
te Poele EM, Siedlinski M, Anne de Pagter
PJ, Bierings MB, Scherpen FJ, Meeuwsen-de Boer TG, Koppelman GH,
Postma DS, Kamps WA, Boezen HM and de Bont ES: MBL2 and fever
during neutropenia in children with acute lymphoblastic leukaemia.
Br J Haematol. 157:132–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao S, Yang J, Qian X, Jin G and Ma H: The
functional polymorphisms of ARID5B and IKZF1 are associated with
acute myeloid leukemia risk in a Han Chinese population. Gene.
647:115–120. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abdel-Wahab O, Mullally A, Hedvat C,
Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara
O, Bhat R, et al: Genetic characterization of TET1, TET2, and TET3
alterations in myeloid malignancies. Blood. 114:144–147. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Petiti J, Rosso V, Lo Iacono M, Calabrese
C, Signorino E, Gaidano V, Berger M, Saglio G and Cilloni D:
Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754
polymorphism in acute myeloid leukemia. Leuk Res. 67:6–11. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu H, Deng J, Zheng J, You Y, Li N, Li W,
Wu D and Zhou Y: Functional polymorphisms in the CD44 gene and
acute myeloid leukemia cancer risk in a Chinese population. Mol
Carcinog. 54:102–110. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim B, Kim S, Lee ST, Min YH and Choi JR:
FLT3 internal tandem duplication in patients with acute myeloid
leukemia is readily detectable in a single next-generation
sequencing assay using the pindel algorithm. Ann Lab Med.
39:327–329. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tien FM, Hou HA, Tsai CH, Tang JL, Chiu
YC, Chen CY, Kuo YY, Tseng MH, Peng YL, Liu MC, et al: GATA2 zinc
finger 1 mutations are associated with distinct clinico-biological
features and outcomes different from GATA2 zinc finger 2 mutations
in adult acute myeloid leukemia. Blood Cancer J. 8:872018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Celton M, Forest A, Gosse G, Lemieux S,
Hebert J, Sauvageau G and Wilhelm BT: Epigenetic regulation of
GATA2 and its impact on normal karyotype acute myeloid leukemia.
Leukemia. 28:1617–1626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee JS, Cheong HS, Koh Y, Ahn KS, Shin HD
and Yoon SS: MCM7 polymorphisms associated with the AML relapse and
overall survival. Ann Hematol. 96:93–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oshrine BR, Olsen MN, Heneghan M, Wertheim
G, Daber R, Wilmoth DM, Biegel JA, Pawel B, Aplenc R and King RL:
Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a
germline ATM variant in an adolescent male with concurrent acute
megakaryoblastic leukemia and mediastinal germ cell tumor. Cancer
Genet. 207:153–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Foster N, Paulsson K, Sales M, Cunningham
J, Groves M, O'Connor N, Begum S, Stubbs T, McMullan DJ, Griffiths
M, et al: Molecular characterisation of a recurrent, semi-cryptic
RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute
myeloid leukaemia. Br J Haematol. 148:938–943. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stirewalt DL, Pogosova-Agadjanyan EL,
Tsuchiya K, Joaquin J and Meshinchi S: Copy-neutral loss of
heterozygosity is prevalent and a late event in the pathogenesis of
FLT3/ITD AML. Blood Cancer J. 4:e2082014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Itzykson R, Kosmider O, Renneville A,
Morabito M, Preudhomme C, Berthon C, Adès L, Fenaux P, Platzbecker
U, Gagey O, et al: Clonal architecture of chronic myelomonocytic
leukemias. Blood. 121:2186–2198. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao T, Jiang N, Liao H, Shuai X, Su J and
Zheng Q: The FLT3-ITD mutation and the expression of its downstream
signaling intermediates STAT5 and Pim-1 are positively correlated
with CXCR4 expression in patients with acute myeloid leukemia. Sci
Rep. 9:122092019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schnittger S, Bacher U, Haferlach C,
Alpermann T, Kern W and Haferlach T: Diversity of the juxtamembrane
and TKD1 mutations (exons 13–15) in the FLT3 gene with regards to
mutant load, sequence, length, localization, and correlation with
biological data. Genes Chromosomes Cancer. 51:910–924. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Patel RK, Weir MC, Shen K, Snyder D,
Cooper VS and Smithgall TE: Expression of myeloid Src-family
kinases is associated with poor prognosis in AML and influences
Flt3-ITD kinase inhibitor acquired resistance. PLoS One.
14:e02258872019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Levis M and Small D: FLT3: ITDoes matter
in leukemia. Leukemia. 17:1738–1752. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun JY, Mu N, Mu J, Li W, Zhang CG and
Wang DM: Expression and significance of PTEN and BCL-2 in acute
myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 26:121–125.
2018.(In Chinese). PubMed/NCBI
|
